A Randomized Pilot Trial for Cryoneurolysis of the Suprascapular Nerve for Perioperative Pain Control After Receiving a Reverse Total Shoulder Arthroplasty

Status: Recruiting
Location: See location...
Intervention Type: Device, Other
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The main purpose of this research is to find out if a treatment called cryoneurolysis can reduce pain after reverse total shoulder replacement surgery. This treatment uses cold to temporarily block a nerve in the shoulder. The study will compare people who receive the treatment to those who do not, to see if it helps lower pain and reduce the need for opioid pain medications after a reverse total shoulder surgery (RTSA).

Eligibility
Participation Requirements
Sex: All
Minimum Age: 30
Maximum Age: 85
Healthy Volunteers: f
View:

• Male patients or female who are not pregnant and do not plan on future pregnancy during trial participation

• between 30-85 years of age

• BMI less than or equal to 45

• Currently setup for an elective primary reverse total shoulder arthroplasty due to primary osteoarthritis

• Ability to provide informed consent to participate in the clinical trial

• Ability to understand and communicate in English

• Willingness to comply with all study procedures

Locations
United States
Texas
Orthopaedic Specialists of Dallas
RECRUITING
Rockwall
Contact Information
Primary
Jeff Neumann, PA-C
jneumann@dallasortho.net
972-503-9495
Time Frame
Start Date: 2025-07-30
Estimated Completion Date: 2026-08
Participants
Target number of participants: 20
Treatments
Active_comparator: Control
Those that do not receive cryoneurolysis of the suprascapular nerve prior to RTSA
Experimental: Intervention
Those that do receive cryoneurolysis of the suprascapular nerve prior to RTSA
Related Therapeutic Areas
Sponsors
Leads: North Texas Medical Research Institute, PLLC
Collaborators: Pacira Pharmaceuticals, Inc

This content was sourced from clinicaltrials.gov